PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
08-Dec-2020 Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas Innovent Biologics
08-Dec-2020 Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas Innovent Biologics
07-Dec-2020 Benitec Biopharma Announces 2020 Annual Stockholder Meeting Benitec Biopharma Inc.
07-Dec-2020 YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY Kite, a Gilead Company
07-Dec-2020 Nokia and Vi CSR deploy SmartAgri solution to enhance farming practices of 50,000 farmers Nokia and Vodafone India Foundation
07-Dec-2020 Medigene AG: Detailed analysis from Medigene's completed Phase I/II DC vaccine in AML patients presented orally at ASH 2020 Medigene
07-Dec-2020 Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer Transgene
07-Dec-2020 Stress and anxiety levels increasing in NHS staff during COVID-19 Nuance
07-Dec-2020 Moberg Pharma publishes prospectus relating to the rights issue Moberg Pharma AB
07-Dec-2020 Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets Kaia Health
07-Dec-2020 Biophytis –Upcoming Potential Value Generating Milestones Biophytis SA
07-Dec-2020 PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery PostEra
07-Dec-2020 JW Therapeutics Presents Data from Pivotal Trial of Relma-cel at the 62nd ASH Annual Meeting JW Therapeutics
07-Dec-2020 Nordic Nanovector to Present at DNB's 11th Annual Nordic Healthcare Conference Nordic Nanovector
07-Dec-2020 KaliVir Immunotherapeutics and Astellas Enter Worldwide Exclusive Licensing Agreement for Development and Commercialization of VET2-L2 Novel Oncolytic Virus KaliVir Immunotherapeutics
07-Dec-2020 Roivant Unveils Targeted Protein Degradation Platform Roivant Sciences
07-Dec-2020 Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study Antengene Corporation Limited
06-Dec-2020 Syndax Pharmaceuticals Announces Additional Positive Data from Phase 1 Trial of Axatilimab in Patients with cGVHD Syndax Pharmaceuticals, Inc.
06-Dec-2020 CTI BioPharma Announces Presentation of Data Supporting Pacritinib's Potential Benefit in Preventing Acute GVHD at the 62nd American Society of Hematology Meeting CTI BioPharma Corp.
06-Dec-2020 CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition CARsgen Therapeutics Co. Ltd.